Oceania > Health

Health in Oceania

  • Vanuatu’s latest hospital theatre opens in north Pentecost

    VANUATU, 2017/07/20 Vanuatu’s new hospital, the Mauna operating theatre in Abwatuntora on Pentecost was opened yesterday and has by presently seen its initial patient, a patient who had reportedly travelled several times before to Vila without being treated successfully. The man has presently been operated in the new theatre on is home island and is pleased with the result. Mauna is the dream of North Pentecost chiefs and people and was initial discussed in 2014. The initial clinically qualified surgeon (as well the initial in the country), Dr Richard Leona, was at that conference and shared the dream of the Raga people.
  • Pacific medical data project gets philanthropic funding boost

    PAPUA NEW GUINEA, 2017/07/20 A project to reduce preventable deaths in the Pacific by improving medical data has received a significant funding boost from a US philanthropist. $US8.7 million has been donated by Bloomberg Philanthropies, taking its total contribution to the Data for Health project to $US18.8 million. The project is jointly financed by the Australian government and is hosted by the University of Melbourne.
  • Flu season: Ways for travelers to protect themselves from springtime bugs

    WORLD, 2017/03/05 Compared to recent years, the 2016-2017 flu season, presently at its peak, is shaping up to be relatively severe. In the US, the flu hospitalization rate was 29.4 per 100,000 people the week of Feb. 10, compared to a rate of 5.1 per 100,000 people during a comparable week in 2016, and pneumonia and mortality rates have presently passed epidemic thresholds. For those taking chance of off-season deals and Spring Break vacations to travel in March, this trend may be particularly alarming – next all, experts say crowded spaces, new germs, recirculated air, and jet lag can make travelers additional vulnerable to the flu.
  • Australians are increasingly returning from overseas with multi-drug-resistant superbugs,

    AUSTRALIA, 2014/02/03 Australians are increasingly returning from overseas with multi-drug-resistant superbugs, prompting warnings for hospitals to isolate high-risk patients to stop their spread. Infectious diseases expert Lindsay Grayson said, until recently, superbug infections in Australia were confined to patients with weakened immune systems who had taken lots of antibiotics. But he said hospitals were facing patients infected with superbugs next overseas travel, and a lot of of them were hospitalised during their trip next becoming ill.
  • N. Zealand to introduce plain packets for tobacco

    NEW ZEALAND, 2013/04/29  New Zealand announced plans Tuesday to force tobacco companies to sell cigarettes in plain packaging, becoming only the second country in the world next Australia to introduce the measure. Associate Health Minister Tariana Turia said banning tobacco branding and selling cigarettes in drab boxes plastered with explicit health warnings “will remove the last remaining vestige of glamour from these deadly products.”
  • Australia's Ramsay teams up with Sime

    INDONESIA, 2013/03/28 Ramsay Health Care Ltd, Australia’s biggest operator of private hospitals, agreed to start an equal joint venture with Sime Darby Bhd to manage their Asian health-care assets. Ramsay’s three hospitals in Indonesia will be combined with Sime Darby’s Malaysian assets, the Sydney-based company said in a statement to the Australian stock exchange today.
  • Australian expansion into the African market

    AUSTRALIA, 2013/03/17 Australian-based pharmaceutical and medical technologies business, LINK Healthcare today announced its expansion into the African market via South Africa’s Equity Pharma Group.
  • Australia Pharmaceuticals & Healthcare Analyse january 2011

    AUSTRALIA, 2011/01/20 The outlook for Australia's pharmaceutical market is challenging. Combined sales of prescription drugs and over-the-counter (OTC) medicines in Australia are estimate to decrease from AUD10.02bn (US$7.95bn) in 2009 to AUD9.30bn (US$7.48bn) in 2014, primarily as a result of the patent cliff. Since the last update of BMI's Pharmaceuticals & Healthcare Statement, we have significantly downgraded our estimate for pharmaceutical sales in Australia.